Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Two female medical researchers looking at computer screen

RACOON-RESCUE is Advancing Pediatric Non-Hodgkin Lymphoma Care

Pediatric Non-Hodgkin Lymphoma (NHL) is the fourth most common tumor in children and adolescents, yet its radiological methods lack standardization, leaving room for significant improvement.

The RACOON-RESCUE project addresses this gap by uniting pediatric radiologists and oncologists from all German university hospitals to systematically analyze imaging data, aiming to enhance diagnosis, treatment response assessment, and follow-up care for pediatric NHL.

The findings from RACOON-RESCUE aim to support the development of optimized and personalized diagnostic and risk-adapted therapeutic approaches.

Read the full interview with the project leads, Prof. Dr. Diane Renz and Prof. Dr. Wilhelm Wößmann, to learn more about the initiative.

Related Resources

Related Resources

A diagram and a CT scan visualizing tumor growth rate in patients with refractory or relapsed lymphoma

Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients

A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™  on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…